STAT3 and renal carcinoma: In this study, we showed that in Caki-1 and 786-O renal cancer cells, STAT3 inhibitor WP1066 inactivated the STAT3 signalling pathway and induced apoptosis, accompanied by reduced Bcl-2 expression.